Karyotype and prognosis in childhood acute lymphoblastic leukemia (ALL) in the UK medical research council (MRC) ALL97 trial.

Karyotype and prognosis in childhood acute lymphoblastic leukemia (ALL) in the UK medical research council (MRC) ALL97 trial.

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Moorman, A, Richards, S, Martineau, M, Cheung, K, Robinson, H, Jalali, G, Broadfield, Z, Harris, R, Barber, K, Lilleyman, J, Kinsey, S, Eden, O, Vora, A, Mitchell, C, Harrison, C
التنسيق:	Conference item
منشور في:	2003

مواد مشابهة

Thioguanine-related veno-occlusive disease (VOD) of the liver in children with acute lymphoblastic leukaemia (ALL): Report from United Kingdom Medical Research Council (UK MRC) trial ALL97.
حسب: Vora, A, وآخرون
منشور في: (2002)

Variables affecting kinetics of minimal residual disease clearance in children with lymphoblastic leukaemia; Results of the United Kingdom Medical Research Council (UK MRC) protocols ALL97, ALL97/99 and ALL2003.
حسب: Vora, A, وآخرون
منشور في: (2005)

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
حسب: Hann, I, وآخرون
منشور في: (2000)

Benefit of targeted intensification for NCI high risk childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council trial ALL97 and ALL97/99.
حسب: Vora, A, وآخرون
منشور في: (2006)

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
حسب: Mitchell, C, وآخرون
منشور في: (2005)

Thioguanine compared with mercaptopurine in childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council randomised trial ALL97.
حسب: Lennard, L, وآخرون
منشور في: (2005)

MRC ALL97/99 - A randomized comparison of dexamethasone versus prednisolone and thioguanine versus mercaptopurine in the treatment of childhood acute lymphoblastic leukemia.
حسب: Mitchell, C, وآخرون
منشور في: (2002)

Prognostic Relevance of Cytogenetics in Childhood Acute Lymphoblastic Leukaemia (ALL): Final Results From MRC ALL97.
حسب: Moor-Man, A, وآخرون
منشور في: (2009)

TEL-AML1 fusion in childhood acute lymphoblastic leukaemia (ALL): Demographics, clinical features, cytogenetic characteristics and prognosis
حسب: Moorman, A, وآخرون
منشور في: (2005)

The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99.
حسب: Mitchell, C, وآخرون
منشور في: (2009)

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial.
حسب: Ensor, H, وآخرون
منشور في: (2011)

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukemia in UK MRC trials.
حسب: Harrison, C, وآخرون
منشور في: (2003)

Acute lymphoblastic leukaemia has a poor outcome in children with Down syndrome due to infective death in remission - (Results of UK MRC ALL 97 trial).
حسب: de la Fuente, J, وآخرون
منشور في: (2005)

Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial.
حسب: Moorman, A, وآخرون
منشور في: (2010)

The clinical pharmacology of thioguanine vs. mercaptopurine in ALL97, a randomized trial for the treatment of childhood lymphoblastic leukaemia
حسب: Lennard, L, وآخرون
منشور في: (2008)

The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers
حسب: Lennard, L, وآخرون
منشور في: (2010)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
حسب: Chessells, J, وآخرون
منشور في: (1994)

A third intensive block of treatment at 35 weeks improves outcome in childhood ALL: Preliminary results from the UKALLXI and ALL97 randomised trials.
حسب: Richards, S, وآخرون
منشور في: (1998)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
حسب: Moorman, A, وآخرون
منشور في: (2007)

Thioguanine versus mercaptopurine in ALL97: thiopurine metabolism and treatment outcome
حسب: Lennard, L, وآخرون
منشور في: (2008)

Improved Outcome for Children and Young Adults with T-Cell Acute Lymphoblastic Leukaemia (ALL): Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
حسب: Vora, A, وآخرون
منشور في: (2008)

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial.
حسب: Moorman, A, وآخرون
منشور في: (2005)

Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials.
حسب: Moorman, A, وآخرون
منشور في: (2013)

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
حسب: Chessells, J, وآخرون
منشور في: (1995)

Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia.
حسب: Harrison, C, وآخرون
منشور في: (2004)

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
حسب: Chessells, J, وآخرون
منشور في: (1997)

Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21).
حسب: Moorman, A, وآخرون
منشور في: (2007)

Clinical significance of blast cell karyotype change at relapse of childhood ALL.
حسب: Vora, A, وآخرون
منشور في: (1996)

Treatment of high risk leukaemia - Results of MRC childhood acute lymphoblastic leukaemia study MRC HR-1.
حسب: Kinsey, S, وآخرون
منشور في: (2002)

Testicular irradiation in childhood lymphoblastic leukaemia. Medical Research Council Working Party on Leukemia in Childhoods.
حسب: Eden, O, وآخرون
منشور في: (1990)

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia.
حسب: Moorman, A, وآخرون
منشور في: (2003)

The Spectrum and Prognostic Relevance of Additional Abnormalities, Involving 12p and 21q, in Children with ETV6-RUNX1 Positive Acute Lymphoblastic Leukaemia (ALL)
حسب: Moorman, A, وآخرون
منشور في: (2008)

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.
حسب: Vora, A, وآخرون
منشور في: (2006)

ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications.
حسب: Martineau, M, وآخرون
منشور في: (2005)

Temporal changes in the incidence and pattern of central nervous system relapses in children with acute lymphoblastic leukaemia treated on four consecutive Medical Research Council trials, 1985-2001.
حسب: Krishnan, S, وآخرون
منشور في: (2010)

Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).
حسب: Hill, F, وآخرون
منشور في: (2004)

Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.
حسب: Ramanujachar, R, وآخرون
منشور في: (2007)

Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial.
حسب: Sive, J, وآخرون
منشور في: (2012)

Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
حسب: Hann, I, وآخرون
منشور في: (1998)

Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome.
حسب: Robinson, H, وآخرون
منشور في: (2003)